Background: Understanding the patterns of cervical cytology use in preventive care may provide useful information for an efficient transition from opportunistic screening to organized programmes. We aimed to identify the determinants of non-use and underuse of cervical cytology in Portuguese women. Methods: As part of the fourth National Health Survey (2005Survey ( /2006, 2191 women aged between 25 and 64 years were evaluated. The previous use of cervical cytology was classified as never or ever, and, among the latter, those having performed the latest cytology testing >5 years before were considered to underuse cervical cytology. We assessed the determinants of non-use and underuse through age-and education-adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs). Results: Overall, 23.5% of women had never used cervical cytology and 10.7% reported underuse. This prevalence increased with age and decreased with education and income. Compared with the national mean, the lowest risk of non-use and underuse was observed in Norte (non-use: OR = 0.31, 95% CI: 0.23-0.42; underuse: OR = 0.60, 95% CI: 0.40-0.91) and the highest in Alentejo (non-use: OR = 2.33, 95% CI: 1.78-3.06; underuse: OR = 2.37, 95% CI: 1.43-3.93). Women without a private health insurance (OR = 2.65, 95% CI: 1.29-5.47), who had no doctor appointments in the preceding 3 months (OR = 2.06, 95% CI: 1.22-3.48) and those who had never performed a mammography (OR = 17.78, 95% CI: 9.09-34.78) were more likely to have never performed a cervical cytology. Conclusion: This study shows inequalities in the use of cervical cancer screening in Portugal and provides useful information for a better allocation of resources for cancer screening.
Introduction

C
ervical cancer is the third most common cancer in women, with 530 000 new cases and 275 000 deaths estimated to have occurred in 2008. 1 Its frequency varies across geographic areas, with >85% of the incident cases taking place in developing countries. Although a human papilloma virus infection, the most important cause of cervical cancer, may be prevented by vaccination, screening is still an important measure for prevention and control of malignancies of the uterine cervix, 2 as the vaccines available do not confer protection against all human papilloma virus types and vaccination has no universal coverage. 3 The European guidelines recommend cervical cancer screening to be conducted in women aged between 20-30 years and 60-65 years, every 3-5 years. 4 However, in 2008, more than half of the European countries had no organized programmes, and opportunistic screening is still the only option available in some of these countries. [5] [6] [7] [8] [9] [10] Although both can be responsible for the decline in cervical cancer mortality, 11, 12 organized screening has the advantage of contributing to reduce the inequalities in the access to early detection, in addition to a higher cost-effectiveness. 12 In Portugal, the region of Centro has organized screening since the 1990s 13 and Alentejo since 2007. 14 Pilot programmes have started in Lisboa e Vale do Tejo (LVT) in 2007, 14 in Norte in 2009 15 and in Algarve in 2010 16 ; however, full coverage of the eligible population was not yet achieved in these regions. In settings where a large proportion of the population undergoes opportunistic screening, the patterns and determinants of cervical cytology use by asymptomatic women need to be taken into account to define the strategies of transition to organized screening, as well as for an accurate estimation of the gains potentially associated with these programmes.
Therefore, we aimed to describe the use of cytology for cervical cancer screening by Portuguese women and to identify the determinants of its non-use or underuse in this setting, using data from the 2005/2006 National Health Survey.
Methods
The present analysis is based on data collected as part of the fourth National Health Survey (IV-NHS); this is a community-based cross-sectional study that evaluated a sample of the Portuguese population (NUTS II -Territorial Nomenclature Units for Statistical Purposes, level II), obtained through complex stratified and cluster sampling.
A sample of households was defined, using data from the 2001 Population and Housing Census, to be used as the sampling frame for household surveys conducted by the National Institute of Statistics (INE). It included 1408 geographical units with at least 240 households each, selected systematically within larger geographical strata, with a probability proportional to the number of households in each unit. A random sample of the households was then selected, and all persons living in these households at the date of the recruitment were eligible. The sample size was defined to ensure a homogeneous distribution of the participants by the seven NUTS II regions.
Between February 2005 and January 2006, 41 193 persons from 15 239 households (76% of those selected) were evaluated. All the information was collected by trained interviewers through computer-assisted personal interviews.
The questionnaire covered 18 thematic areas, and included questions that were used to obtain information from all selected participants, even if answered by a proxy, whereas some of them could not be answered by a proxy. Data on six of these areas were collected only in one of the four trimesters, to ensure that the average duration of the interviews did not exceed 75 min/household.
Cervical cytology testing was assessed in a section referring to 'Preventive Care'. It was introduced with the statement 'Now I would like to make you some brief questions about people's actions to prevent diseases', followed by the question 'In which year did you have your latest cytology (vaginal smear, pap smear)?'. This information was collected from women aged 20 years and older, between the 27th and 39th weeks of data collection. A total of 3368 women provided information on cervical cancer screening, and our analyses were restricted to those aged between 25 and 64 years (n = 2191), as this is the age range targeted by the only organized programme conducted in Portugal when these data were collected.
Women reporting a previous cervical cytology were classified as ever users, and grouped further according to the time since the latest cytology testing: up to 5 years and >5 years. The latter category was defined as underuse.
We computed the prevalence of cervical cytology testing and used non-conditional logistic regression to compute age-and educationadjusted odds ratios (ORs) and respective 95% confidence intervals (95% CIs) to assess the determinants of never having being screened and of underuse. All analyses were conducted with STATA Õ , version 9.2 (StataCorp LP, College Station, Texas, USA), using sampling weights computed based on the inverse of the probability of selection of each sampling unit, further corrected for nonresponses and for the effective number of subjects evaluated, regarding the age and sex structures.
Results
Approximately 40% of the women had 4 or less years of schooling, nearly one-third had a monthly family income between E501 and E900 and most of them were legally married or cohabiting with a partner (table 1) .
A total of 76.5% of the women reported to have performed cytology for cervical cancer screening before; 68.3% in the past 5 years and 8.2% >5 years ago. The prevalence of cervical cytology use was the highest among women aged 35-44 years (83.2%) and lowest among those aged 55-64 years (70.2%). However, among women who had been screened before, the prevalence of underuse increased with age, from 5.6% in those aged 25-34 years to 24.0% in those aged 55-64 years (figure 1).
Compared with the national mean, women living in Alentejo (OR = 2.33, 95% CI: 1.78-3.06) and in R.A. Açores (OR = 2.41, 95% CI: 1.90-3.06) were more likely to have never performed a cervical cytology, whereas the opposite occurred in the Norte (OR = 0.31, 95% CI: 0.23-0.42) and in LVT (OR = 0.60, 95% CI: 0.45-0.79) (table 2). The proportion of women who had never used cytology for cervical cancer screening increased from the highest to the lowest levels of education (P for trend <0.001) and family income (P for trend <0.001). Single women were more likely to have never performed a cervical cytology than the married (OR = 5.69, 95% CI: 3.65-8. Figure 1 Prevalence of cervical cytology use in Portugal, according to the elapsed time since the latest testing and the age 9.09-34.78) were more likely to have never performed a cervical cytology. Among the women who underwent a cervical cytology before, compared with the national mean, those living in Alentejo were more likely to have been tested >5 years before (OR = 2.37, 95% CI: 1.43-3.93), whereas the opposite occurred in the Norte (OR = 0.60, 95% CI: 0.40-0.91) (table 3). The prevalence of underuse increased with decreasing education (P for trend <0.001) and monthly family income (P for trend <0.001). Women who had a partner in the past but not at this moment (OR = 2.15, 95% CI: 1.18-3.90) and those who had the National Health Service (Serviço Nacional de Saúde) as the only public health-care provider (OR = 2.26, 95% CI: 1.12-4.54) were more likely to underuse cervical cytology. No significant differences were observed according to parity, body mass index, smoking, private health insurance, doctor appointments or mammography screening.
Discussion
About one-quarter of women never performed a cervical cytology and, among those who had been tested at least once, approximately one-tenth reported underuse. Both cytology non-use and underuse among eligible women for cervical cancer screening varied across geographic regions and with sociodemographic characteristics and access and use of health-care services.
This study evaluated a large representative sample of Portuguese women and provides important information for understanding the patterns of cervical cytology use in our setting, which is in transition from mainly opportunistic screening to organized programmes, as many other European countries. [5] [6] [7] [8] [9] [10] The prevalence of cytology use according to the recommendations for cervical cancer screening observed in our study (68.3%) is in line with the ones reported in other southern European countries. In Spain, the adherence to screening recommendations was 67.4%, 19 whereas in Italy, >50% of women had been tested within the past 3 years. 20 We identified geographic differences in the use of cervical cytology among Portuguese women. However, the contribution of opportunistic and organized screening for the overall cytology use could not be quantified, as no information was available to distinguish between examinations performed opportunistically and those conducted within screening programmes. The only Portuguese region with an organized programme at the time of the IV-NHS was Centro. The programme started in 1990, 13 but full coverage was only achieved in 2006, 21 which possibly contributes to the lack of significant differences in the prevalence of non-use and underuse between this region and the national mean. Furthermore, when excluding the women living in Centro from the analyses (n = 349), the results remained similar, which suggests that the main correlates of non-use and underuse observed in our study were related to opportunistic screening.
In the other regions, cervical cancer screening was opportunistic at the time the IV-NHS was conducted. Organized screening was implemented in Alentejo in 2007, 14 and pilot programmes have started in LVT in 2007, 14 in Norte in 2009 15 and in Algarve in 2010, 16 whereas the other two regions (R.A. Açores and R.A. Madeira) still have opportunistic screening only. The region of Norte consistently presents a lower prevalence of non-use and underuse, whereas LVT presents a proportion of cytology non-use lower than the national mean. These results probably reflect an easy access to opportunistic screening in these regions, as they include the two major urban centres of Portugal: Lisboa in LVT and Porto in Norte, and represent 71.5% of the eligible Portuguese women. This is also in accordance with a study conducted in Porto, between 2005 and 2008, which has shown a high life prevalence of cervical cytology use, with most of women being tested annually. 22 The easy access to opportunistic screening may contribute to a low adherence to organized programmes, especially by women who are i: Women were classified as never smokers if they had never consumed tobacco, ex-smokers if they had consumed tobacco in the past but were not consuming it at the time of the interview or current smokers if they consumed tobacco at the time of the interview, including daily and occasionally. j: In Portugal, an NHS is provided to all citizens; however, other health subsystems exist besides NHS for specific professions/occupations (e.g. health-care from the military service of the army) as public health-care providers. k: Only asked to women aged 20 years and older, but for analysis, only women aged 45 years and older, according to the breast cancer screening policy adopted in Portugal, 18 were considered.
usually tested more frequently than recommended for organized programmes 12, 23, 24 ; unfortunately, the lack of information regarding the frequency and/or regularity with which the tests were performed precludes an estimation of cervical cytology overuse in the present study. This reasoning is supported by the low participation rates in the pilot programmes of Norte and LVT compared with Alentejo and Algarve (5 and 9%, respectively, vs. 45 and 38%, respectively 15, [25] [26] [27] ). These differences suggest that the implementation of organized programmes may be expected to result in higher prevalences of screening in the future in regions such as Alentejo, Algarve, R.A. Açores and R.A. Madeira, whereas the transition from opportunistic to organized screening may not be straightforward in the settings where the former is frequent.
The incidence rate of cervical cancer in Portugal was 10.0/100 000 in 2005 and 11.1/100 000 in 2006. In Portugal, three regional population-based cancer registries exist since the 90s covering the north, central and south regions of the country. While LVT, Alentejo, Algarve and R.A. Madeira are covered by the south registry, in R.A. Açores, a registry was only implemented in 2007. 10 Only the cancer registry of Centro has been publishing data on in situ cervical cancer. Comparing the rates of invasive cervical cancer in 2005 and 2006, the lowest figures were observed in Centro (9.0/ 100 000 in 2005 and 8.1/100 000 in 2006) 28, 29 and the highest in the south (11.3/100 000 in 2005 and 12.0/100 000 in 2006). 30, 31 The south registry also presents data stratified by smaller regions than the ones considered in the IV-NHS; the incidence rates were higher for regions included in LVT and Algarve than Alentejo or R.A. Madeira. 30, 31 In the north, the rates were 10.9/100 000 in 2005 and 9.3/100 000 in 2006. 32, 33 These differences are expected to reflect the extent to which organized and opportunistic screening has been conducted in these regions over the years, but the crosssectional design of our study and the heterogeneous quality of the data provided by the different cancer registries 34, 35 do not allow inference regarding the effectiveness of screening in these settings.
In our study, education, family income and participation in breast cancer screening were associated to cervical cytology never and underuse. These findings are in accordance with previous observations in other settings, where these characteristics were related to a more frequent use of preventive care. [36] [37] [38] Women with higher levels of education and income may have a better risk perception and more information about the benefits of prevention, as well as more facilitated access to health-care services. 36, 37, [39] [40] [41] [42] A relationship between healthy lifestyles and the use of cervical cytology would be expected, as women with healthy behaviours could also have greater health concerns, but this was not confirmed by our study, possibly because non-use and underuse is primarily explained by differences in the sociodemographic characteristics.
Our analyses were based on the latest NHS conducted in Portugal. Despite the data refer to [2005] [2006] , this report provides important information for understanding the patterns of cervical cancer screening in the country. Nevertheless, some limitations need to be discussed.
The data used in these analyses were self-reported and an overestimation of the prevalence of cervical cytology use could be expected, compared with data retrieved from clinical records, 43, 44 probably due to a social desirability bias. 45 In the present study, no data were available regarding the age at onset of sexual activity and this may also have contributed to overestimation of cervical cytology use, especially in younger women. Furthermore, the fact that it is not possible to ensure that all the reports referred to screening cytology may have probably led to an overestimation of the prevalence of cervical cancer screening, but it is unlikely that tests conducted for other reasons account for a meaningful proportion of the reported use.
In conclusion, a large proportion of women within the age range eligible for cervical cancer screening were never tested or The prevalence in each region was compared with the national mean by computing the deviations from the grand mean using deviation coding. c: Also includes participants with >12 years of non-university education. d: Corresponds to the total income of all persons living in the household. e: Includes individuals who are legally married or cohabiting. f: Includes individuals who had a partner in the past but not at this moment. g: Only asked to women aged between 15 and 55 years. h: Self-reported weight and height were used to compute BMI, which was divided into three categories according to the World Health Organization guidelines. 17 i: Women were classified as never smokers if they had never consumed tobacco, ex-smokers if they had consumed tobacco in the past but were not consuming it at the time of the interview or current smokers if they consumed tobacco at the time of the interview, including daily and occasionally. j: In Portugal, an NHS is provided to all citizens; however, other health subsystems exist besides NHS for specific professions/occupations (e.g. health-care from the military service of the army) as public health-care providers. k: Only asked to women aged 20 years and older, but for analysis, only women aged 45 years and older, according to the breast cancer screening policy adopted in Portugal, 18 were considered.
were tested less frequently than recommended. This study shows inequalities in the use of cervical cancer screening in Portugal and provides useful information for a better allocation of resources for cancer screening.
